Market Overview

Allergan to Buy Kythera Biopharma for $2.1B in Cash & Stock, $75/Shr

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News M&A Press Releases

 

Related Articles (AGN + KYTH)